BBIO – Encaleret – Chronic Hypoparathyroidism – Proof of Concept Study in Post-Surgical Hypoparathyroidism

BridgeBio Pharma Inc. published this content on September 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 06, 2025 at 18:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]